{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T16:35:54Z","timestamp":1786379754179,"version":"build-2736575974"},"reference-count":62,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"CSL Vifor Spain"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/13696998.2025.2501874","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T12:12:37Z","timestamp":1748088757000},"page":"835-847","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Cost-utility analysis of difelikefalin for the treatment of moderate to severe Chronic Kidney Disease associated-Pruritus (CKD-aP) in adult patients receiving haemodialysis in Spain"],"prefix":"10.1080","volume":"28","author":[{"given":"Emilio","family":"S\u00e1nchez-Alvarez","sequence":"first","affiliation":[{"name":"Nephrology Unit Cabue\u00f1es Hospital Gijon","place":["Asturias, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose-Lu\u00eds","family":"Poveda","sequence":"additional","affiliation":[{"name":"Pharmacy Unit, Hospital Universitari i Polit\u00e8cnic La Fe","place":["Valencia, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"S\u00e1nchez-Villanueva","sequence":"additional","affiliation":[{"name":"Nephrology Unit, La Paz Hospital Madrid","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"De La Paz Ca\u00f1izares","sequence":"additional","affiliation":[{"name":"Alira Health","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ramirez de Arellano","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research, CSL Vifor","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Ruiz-Andr\u00e9s","sequence":"additional","affiliation":[{"name":"Market Access, CSL Vifor","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13080527"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2022.04.009"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.7759\/CUREUS.5256"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.NEFRO.2020.12.010"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.454"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/NDT\/GFL461"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/CKJ\/SFAC246"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/JCM12134505"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011393.PUB2"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2023.07.002"},{"key":"e_1_3_5_12_1","unstructured":"KDIGO-Pruritus-Infographic-Set. ; n.d."},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S52985"},{"key":"e_1_3_5_14_1","first-page":"459","article-title":"en representaci\u00f3n del Grupo Espa\u00f1ol de Prurito Asociado a ERC. Information and consensus document for the diagnostic and therapeutic management of pruritus associated with chronic kidney disease in patients on haemodialysis in Spain","volume":"44","author":"Buades JM","year":"2023","unstructured":"Buades JM, Figueras-Nart I, Goicoechea M, et\u00a0al. en representaci\u00f3n del Grupo Espa\u00f1ol de Prurito Asociado a ERC. Information and consensus document for the diagnostic and therapeutic management of pruritus associated with chronic kidney disease in patients on haemodialysis in Spain. Nefrologia. 2023;44:459\u2013614. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2013251424001342.","journal-title":"Nefrologia"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/S11255-007-9188-8"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03000906"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/NDT\/18.1.126"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/NDT\/GFM630"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/S11136-011-9964-X"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.5665\/SLEEP.1382"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/SJ.KI.5000251"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03280317"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3125"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/KI.2013.77"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/JCMM.14170"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.JAD.2011.01.011"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/JAMA.2010.619"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/SLEEP\/ZSY047"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/CKJ\/SFAB142"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00100110"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.23876\/J.KRCP.2018.37.2.138"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.NEFRO.2017.09.004"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.08.1878"},{"key":"e_1_3_5_34_1","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Bolet\u00edn mensual de seguridad de la AEMPS sobre medicamentos de uso humano del mes de octubre de 2022; 2022. https:\/\/www.aemps.gob.es\/informa\/boletin-mensual-de-seguridad-de-la-aemps-sobre-medicamentos-de-uso-humano-del-mes-de-octubre-de-2022\/."},{"key":"e_1_3_5_35_1","unstructured":"GOV.UK. Pregabalin (Lyrica) gabapentin (Neurontin) and risk of abuse and dependence: new scheduling requirements from 1 April 2019. https:\/\/www.gov.uk\/drug-safety-update\/pregabalin-lyrica-gabapentin-neurontin-and-risk-of-abuse-and-dependence-new-scheduling-requirements-from-1-april."},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.3389\/FPSYT.2021.639780"},{"key":"e_1_3_5_37_1","unstructured":"Committee for Medicinal Products for Human Use (CHMP). Difelikefalin Public Assessment Report; 2022. https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/kapruvia-epar-public-assessment-report_en.pdfhttps:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/kapruvia-epar-public-assessment-report_en.pdf."},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA1912770\/SUPPL_FILE\/NEJMOA1912770_DATA-SHARING.PDF"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2022.100512"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.XKME.2022.100513"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.XKME.2022.100542"},{"key":"e_1_3_5_42_1","unstructured":"Ortega Eslava A Mar\u00edn Gil R Fraga Fuentes MD et\u00a0al. Gu\u00eda de evaluaci\u00f3n econ\u00f3mica e impacto presupuestario en los informes de evaluaci\u00f3n de medicamentos. Sociedad Espa\u00f1ola de Farmacia Hospitalaria; 2016.\u00a0https:\/\/gruposdetrabajo.sefh.es\/genesis\/genesis\/Documents\/GUIA_EE_IP_GENESIS-SEFH_19_01_2017.pdf."},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gaceta.2009.07.011"},{"key":"e_1_3_5_44_1","unstructured":"Puig-Junoy J Oliva-Moreno J Trapero-Bertr\u00e1n M et\u00a0al. Gu\u00eda y recomendaciones para la realizaci\u00f3n y presentaci\u00f3n de evaluaciones econ\u00f3micas y an\u00e1lisis de impacto presupuestario de medicamentos en el \u00e1mbito del CatSalut; 2014. Generalitat de Catalunya. Departament de Salut. Servei Catal\u00e0 de la Salut: Barcelona 2014. https:\/\/scientiasalut.gencat.cat\/bitstream\/handle\/11351\/1057\/guia_recomanacions_avaluacions_economiques_medicaments_catsalut_2014_cas.pdf."},{"key":"e_1_3_5_45_1","unstructured":"Comit\u00e9 Asesor para la Financiaci\u00f3n de la Prestaci\u00f3n Farmac\u00e9utica del Sistema Nacional de Salud. Gu\u00eda de evaluaci\u00f3n econ\u00f3mica de medicamentos; 2023. https:\/\/www.sanidad.gob.es\/areas\/farmacia\/comitesAdscritos\/prestacionFarmaceutica\/docs\/20240227_CAPF_Guia_EE_definitiva.pdf."},{"key":"e_1_3_5_46_1","unstructured":"Committee for Medicinal Products for Human Use (CHMP). Difelikefalin annex i summary of product characteristics. Kapruvia | European Medicines Agency (EMA). Consulted in May 2022."},{"key":"e_1_3_5_47_1","unstructured":"CSL Vifor Internal information."},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3164"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0253966"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v045.i03"},{"key":"e_1_3_5_51_1","first-page":"37","article-title":"Evaluaci\u00f3n econ\u00f3mica del tratamiento sustitutivo renal (hemodialisis, dialsis peritoneal y trasplante)","volume":"1","author":"Arrieta J.","year":"2010","unstructured":"Arrieta J. Evaluaci\u00f3n econ\u00f3mica del tratamiento sustitutivo renal (hemodialisis, dialsis peritoneal y trasplante). Nefrologia. 2010;1:37\u201347. https:\/\/www.revistanefrologia.com\/es-evaluacion-economica-del-tratamiento-sustitutivo-articulo-X2013757510002348.","journal-title":"Nefrologia"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.XKME.2020.08.011"},{"key":"e_1_3_5_53_1","article-title":"Registro Espa\u00f1ol de Enfermos Renales (REER)","author":"Mahillo B.","year":"2021","unstructured":"Mahillo B. Registro Espa\u00f1ol de Enfermos Renales (REER). Informe. 2021;56\u201363. https:\/\/www.senefro.org\/contents\/webstructure\/MEMORIA_REER_2021_PRELIMINAR.pdf.","journal-title":"Informe"},{"key":"e_1_3_5_54_1","unstructured":"BOTPLUS 2022. https:\/\/botplusweb.farmaceuticos.com\/. (accessed May 27 2024)."},{"key":"e_1_3_5_55_1","unstructured":"eSalud. Informaci\u00f3n econ\u00f3mica del sector sanitario; 2022. http:\/\/esalud.oblikue.com."},{"key":"e_1_3_5_56_1","unstructured":"Instituto Nacional de Estad\u00edstica (INE); 2022. https:\/\/www.ine.es."},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1130-6343(05)73695-3"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/CKJ\/SFAD032"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2011.00037"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.5301\/jn.5000132"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.GACETA.2019.06.007"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199813040-00003"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2015.279"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2025.2501874","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:49:22Z","timestamp":1766400562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2025.2501874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/13696998.2025.2501874"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2025.2501874","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-02-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}